LYRA Lyra Therapeutics Inc
1,145
$0.3251
$0.0172
(5.03%)
| Watchers | 1,145 |
| 52-Wk Low | $0.3352 |
| 52-Wk High | $6.79 |
| Market Cap | $20.87M |
| Volume | 2.54M |
| 52-Wk High | $6.79 |
| 52-Wk Low | $0.3352 |
Why Lyra Therapeutics Stock Is Down 93% TodayBenzinga • 17 days ago
Lyra Therapeutics shares are trading lower by 93% to $0.30 during Monday's session. The company announced the ENLIGHTEN 1 trial did not meet its primary endpoint.
read more...
Share to Feed
LYRA's total volume now sits at 2M. The +0.16% price change was insignificant, leaving IBM's price at $6.23...
This indicator may be signaling that LYRA's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
LYRA's total volume now sits at 700.8K. The +0.99% average daily price change was insignificant these 3 days, leaving LYRA's price at $6.13...
LYRA Meets Analyst Expectations for Earnings Per Share, Reveals Full Year and Q4 2023 FinancialsRelated Stocks: LYRA...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
LYRA stock results show that Lyra Therapeutics beat analyst estimates for earnings per share but missed on revenue for the fourth...
Lyra Therapeutics reports Q4 results...
-- Data from ENLIGHTEN I Pivotal Phase 3 Trial of LYR-210 in Chronic Rhinosinusitis (CRS) Anticipated Q2 2024 -- WATERTOWN, Mass., March 21, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc...
Lyra Therapeutics, Inc. (NASDAQ:LYRA Get Free Report) was the target of a significant decrease in short interest during the month of February. As of February 29th, there was short interest...